Final-Program-ATS-2023-AP.vp

202

MONDAY • MAY 22

2:15 Overview of Lung Aging

exacerbations and/or medication side effects. Recent advances in asthma biology and in technology have provided exciting opportunities to improve personalized severe asthma management. Leveraging insights from the NHLBI Precise network and ICAN meeting, we will provide an update on the latest insights in this field. Chairing: H. Durrington, PhD, MA, MBChB, Manchester, United Kingdom A.A. Zeki, MD, Davis, CA B. Gaston, MD, Indianapolis, IN 2:15 Application of an Adaptive Trial Design to Severe Asthma Research A. Ivanova, PhD, Chapel Hill, NC 2:28 Questions and Answers 2:33 Androgens and Other Sex Hormones in Severe Asthma D.C. Newcomb, PhD, Nashville, TN 3:46 Questions and Answers 2:51 Potential Use of Genetics and Biomarkers to Personalize Severe Asthma Management V.E. Ortega, MD, PhD, ATSF, Scottsdale, AZ 3:04 Questions and Answers 3:09 Asthma Imaging: Novel Insights E. Dunican, BM BCH, Dublin, Ireland 3:22 Questions and Answers 3:27 Recent Advances in At-Home Assessments of Asthma Control P. Akuthota, MD, ATSF, La Jolla, CA 3:46 Questions and Answers

J.L. Schneider, MD, PhD, Boston, MA 2:30 Oxidative Shifts in the Aging Lung I. Rahman, PhD, ATSF, Rochester, NY 2:40 Signalling and Senescence in Lung Aging A.L. Mora, MD, Columbus, OH 2:50 Mutation and Epimutation Changes with Age S.D. Spivack, MD, MPH, Bronx, NY 3:00 Extracellular Matrix and Aging in the Lung

J.K. Burgess, BSc, PhD, ATSF, Groningen, Netherlands 3:10 Distal Bronchoalveolar Region Changes in Aging and COPD R. Shaykhiev, MD, PhD, NEW YORK, NY 3:20 Immunologic Signaling and Exhaustion in the Aging Lung B. Ural, PhD, New York, NY 3:30 Multiomic Revelations in Lung Aging and IPF N. Kaminski, MD, ATSF, New Haven, CT 3:40 Panel Discussion S.D. Spivack, MD, MPH, Bronx, NY

BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM

B92

INNOVATIVE APPROACHES TO PERSONALIZED SEVERE ASTHMA MANAGEMENT

Assemblies on Allergy, Immunology and Inflammation; Behavioral Science and Health Services Research; Clinical Problems; Pediatrics; Respiratory Cell and Molecular Biology 2:15 PM - 3:45 PM Walter E. Washington Convention Center Ballroom B (Level 3) Target Audience Adult and pediatric asthma providers, including pulmonologists, allergists and APPs, as well as basic scientists interested in airway immunology, epithelial and airway smooth muscle biology and new companies in the severe asthma space Objectives At the conclusion of this session, the participant will be able to: • apply home assessments to longitudinal asthma management • describe new findings regarding androgens and other sex steroids in asthma • describe new insights regarding the use of imaging in asthma Biologic treatments have been beneficial for many severe asthma patients, but many others continue to have debilitating chronic dyspnea,

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

B93

BREAKTHROUGHS IN ILD: TRANSLATION TO THE BEDSIDE

2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Ballroom C (Level 3)

Chairing: J. Koenitzer, MD, PhD, Saint Louis, MO W.P. Drake, MD, Nashville, TN J. Joshua, MD, San Diego, CA Oral Presentations: 2:15 Comprehensive Myositis Antibody Panels Improve Recognition of Myositis Related Interstitial Lung Disease/ A.E. Davis, Nashville, TN

ATS 2023 • Washington, DC